Skip to Content
Biotechnology

A machine can now keep livers alive outside the body for a week

January 14, 2020
Doctors working on a transplant
Doctors working on a transplant
Doctors working on a transplantAssociated Press

The news: A machine has been developed that can keep human livers alive for seven days. It also seems to help improve the quality of the livers.

How it works: The machine re-creates a level of pressure similar to that found inside the body, and pumps oxygen, blood, and nutrients to the livers while removing cell waste products like carbon dioxide. The amounts of nutrients, blood, and oxygen are automatically adjusted by algorithms, meaning the machine doesn’t require constant supervision, according to a study in Nature Biotechnology.

On to humans: The team responsible, from the University of Zurich in Switzerland, has been developing the machine for four years, experimenting using pig livers. For the latest test the researchers used 10 human livers that were too damaged for transplant. Six of the livers survived and seemed to be healthier, with lower levels of compounds linked to injury. 

The potential: Livers can currently only be stored for up to 24 hours on ice before transplant, so a machine that can keep them alive for a week could allow many more people to get transplants. There are about 17,000 people waiting for a liver in the US right now, with an average waiting time of almost a year.

Next steps: The researchers still have some way to go to prove that the invention can work in practice, and that livers stored this way would be safe when transplanted into patients. 

Sign up here to our daily newsletter The Download to get your dose of the latest must-read news from the world of emerging tech. 

Deep Dive

Biotechnology

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

individual aging affects covid outcomes concept
individual aging affects covid outcomes concept

Anti-aging drugs are being tested as a way to treat covid

Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

Workers disinfect the street outside Shijiazhuang Railway Station
Workers disinfect the street outside Shijiazhuang Railway Station

Why China is still obsessed with disinfecting everything

Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.